"False"
Skip to content
printicon
Main menu hidden.

Molecular medicine

Latest news

Postdoktor Yu-Cheng Qian och gästforskare Abdullah Azmi arbetar i vibrationslabbet.
How vibrations induced by snoring may contribute to sleep apnea

Umeå researchers show vibrations weaken upper airway muscles, making them collapse during sleep.

Oliver Billker
Professor vid Institutionen för molekylärbiologi
Enhet: Grupp Oliver Billker
Anknuten som forskare till Molekylär Infektionsmedicin, Sverige (MIMS)
Roll: Föreståndare
Oliver Billker awarded the Torgny och Lena Stigbrand Prize

Receives the award for his pioneering work in malaria research.

Sun Nyunt Wai, professor i medicinsk mikrobiell patogenes, bedriver forskning om sjukdomsframkallande bakteriers egenskaper på molekylär nivå.  <br/>Professor vid Institutionen för molekylärbiologi Enhet: Grupp Sun Nyunt Wai
Sun Nyunt Wai awarded for outstanding bacterial research

Professor Sun Nyunt Wai is awarded the Bo and Barbro Hammarström Prize in 2026.

Biträdande universitetslektor vid Institutionen för klinisk mikrobiologi Enhet: Avdelningen för virologi
2025 MIMS Investigator Award Announcement

MIMS announces four recipients of the 2025 MIMS Investigator Award.

Bild för Wendy Wu projekt
Discovery on how aggressive breast cancer controls protein production

A mechanism that increases our understanding of how breast tumours grow and adapt has been discovered.

Exciting findings from an antibiotic discovery project with labhead Barbara Sixt and colleague Aakriti Singh and Magnus Ölander, postdoc in the Sixtlab,
Barbara Sixt awarded ERC Consolidator Grant

ERC provides funding for five years to Barbara Sixt's research on chlamydia.

Features

Stephan Wenkel och Iker Valle Aramburu forskar båda om mikroproteiner, Stephan i växter och Iker inom immunförsvar och samspel mellan värdar och mikroorganismer. Tillsammans arrangerade de Nobelsymposiet om mikroproteiner vid Umeå universitet i september 2026.
Tiny proteins are proving hard to ignore

Once overlooked, tiny proteins are revealing surprising roles in biology – and new possibilities for research.

Illustration gensax
CRISPR-Cas9 – the gene-editing tool that changed the world

A breakthrough in Umeå laid the foundation for CRISPR-Cas9, a revolutionary tool.

Elin Chorell, forskare vid Institutionen för folkhälsa och klinisk medicin, avdelningen för medicin.
Aiming to detect and halt type 2 diabetes

Her goal is to make it possible to detect and slow the progression of type 2 diabetes at an early stage.

Mateus lab
Gut bacteria can provide clues to curing diseases

André Mateus researches how drugs and the microbiome in the human gut work together.

Nasim Sabouri
Four-stranded DNA in a new type of cancer therapy

Nasim Sabouris research findings are forming the basis for efforts to develop new cancer therapeutics.

Biträdande universitetslektor Francesca Aguilo vid Institutionen för medicinsk biovetenskap i labbet med kollegor.
Targeting cancer cells without affecting healthy cells

Francesca Aguilos work lies at the cutting edge of biomedical research and cancer.

Research groups

Sophia Harlid´s research group
We study the connection between our environment, our genes and our health.
Teresa Frisan Lab
We study the role of bacterial genotoxins in modulation of intestinal mucosa homeostasis.
Ulf Ahlgren
More on grp Ulf Ahlgrens ongoing research.
Research area: Molecular medicine
Umeå Extracellular Vesicle Network
links groups working on extracellular vesicles (EVs) at Umeå University and Umeå University Hospital (Norrlands Universitetssjukhus) and acts as a nod
Verena Kohler Lab
Implications of ageing and disease on cellular protein quality control.
Vivien Horváth
Functional Neurogenomics

Research projects

High-speed mid-infrared photothermal imaging of fatty acids and lipid droplets in living cells
Duration 1 January 2023 until 31 December 2026
Type of project Research project
Development of a new tularemia vaccine
Duration 1 January 2021 until 31 December 2025
Type of project Research project
Prostate cancer therapy for COVID-19
Duration 8 June 2020 until 31 May 2022
Type of project Research project
Artificial intelligence in oncology: European REVERT
Duration 1 January 2020 until 31 December 2023
Type of project Research project
Mosquito-borne zoonosis in animals and humans
Research area: Molecular medicine
Duration 1 January 2015 until 31 December 2017
Type of project Research project
Neuromuscular injuries in Obstructive Sleep Apnea
Duration 10 October 2013
Type of project Research project
CD47 and signal regulatory protein a (SIRP a) modulates innate immune and autoimmune responses
Research area: Molecular medicine
Duration 28 October 2011 until 31 December 2013
Type of project Research project